# Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma

> **NCT00693602** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 87 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Non Hodgkins Lymphoma

## Interventions

- **DRUG:** Erwinase

## Key facts

- **NCT ID:** NCT00693602
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2017-04-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693602, "Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00693602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*